FDA in Their Virtual Meeting: We Were Falsely Mislead by Pfizer About the Safety of the Vaxxine. Heart Attacks Are 71x Higher Than Other Vaxxines
By Francis Boulle
Vaccines and Related Biological Products Advisory Committee
U.S. Food and Drug Administration
Vaccines and Related Biological Products Advisory Committee meeting to discuss Pfizer-BioNTech’s supplemental Biologics License Application for administration of a third dose, or “booster” dose, of the COVID-19 vaccine, Comirnaty, in individuals 16 years of age and older.